medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Number 4

<< Back Next >>

Ann Hepatol 2011; 10 (4)

Hepatology Highlights

Méndez-Sánchez N

Language: English
References: 10
Page: 418-420
PDF size: 32.81 Kb.


Text Extraction

Do older patients utilize excess health care resources after liver transplantation?

Shankar N, et al. The aim of this study was to determine if patients ≥ 60 years of age utilize more health resources following liver transplantation compared with younger patients. The authors found that recipients ≥ 60 years of age have similar lengths of hospitalization, re-operative rates, need for consultative services and readmission rates following liver transplantation, but have longer lengths of stay in the intensive care. The importance of this study is because elderly patients with cirrhosis are at increased risk of having co-morbidity conditions that complicate its management, and cirrhosis in the elderly is a cause of increased mortality from both hepatic and non-hepatic causes.


REFERENCES

  1. Shankar N, AlBasheer M, Marotta P, Wall W, McAlister V, Chandok N. Do older patients utilize excess health care resources after liver transplantation? Ann Hepatol 2011; 10(4): 477-81.

  2. Hoshida Y, Ikeda K, Kobayashi M, Suzuki Y, Tsubota A, Saitoh S, et al. Chronic liver disease in the extremely elderly of 80 years or more: Clinical characteristics, prognosis and patient survival analysis. J Hepatol 1999; 31: 860-6.

  3. Keswani RN, Ahmed A, Keeffe EB. Older age and liver transplantation: a review. Liver Transpl 2004; 10: 957-67.

  4. Perry DK, Willingham DL, Sibulesky L, Bulatao IG, Nguyen JH, Taner CB. Should donation after cardiac death liver grafts be used for retransplantation? Ann Hepatol 2011; 10(4): 482-5.

  5. Abou-Abbass A, Abouljoud M, Yoshida A, Kim DY, Slater R, Hundley J, Kazimi M, Moonka D. Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease. Transplant Proc 2010; 42: 3392-8.

  6. Cabrera-Álvarez G, Gómez-Galicia D, Rodríguez-Fragoso L, Madrid-Marina V, Cañedo-Dorantes L, Sánchez-Alemán M, Méndez-Sánchez N, Reyes-Esparza J. Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin. Ann Hepatol 2011; 10(4): 458-68.

  7. Maylin S, Martinot-Peignoux M, Moucari R, et al. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology 2008; 135: 821-9.

  8. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004; 103: 1364-9.

  9. Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 2002; 102: 887-95.

  10. Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 357: 2237-47.




2020     |     www.medigraphic.com